Lanean...
Design, synthesis and evaluation of anti-CD123 antibody drug conjugates
Leukemia stem cells (LSCs) account for the development of drug resistance and increased recurrence rate in acute myeloid leukemia (AML) patients. Targeted drug delivery to leukemia stem cells remains a major challenge in AML chemotherapy. Overexpressed interleukin-3 receptor alpha chain, CD123, on t...
Gorde:
| Argitaratua izan da: | Bioorg Med Chem |
|---|---|
| Egile Nagusiak: | , , , , , , , |
| Formatua: | Artigo |
| Hizkuntza: | Inglês |
| Argitaratua: |
2016
|
| Gaiak: | |
| Sarrera elektronikoa: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5318162/ https://ncbi.nlm.nih.gov/pubmed/27687970 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.bmc.2016.09.043 |
| Etiketak: |
Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!
|